Fluimukan Akut 600 mg šumeće tablete
| Name | Fluimukan Akut 600 mg šumeće tablete |
|---|---|
| Former Name | Fluimukan Long 600 mg šumeće tablete |
| Marketing Authorisation Number | HR-H-690851861 |
| Active Substance | acetilcistein |
| Composition | jedna šumeća tableta sadrži 600 mg acetilcisteina |
| Pharmaceutical Form | šumeća tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Salutas Pharma GmbH, Barleben, Njemačka Lek S.A., Varšava, Poljska Hermes Pharma GmbH, Wolfratshausen, Njemačka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 04.10.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/406 |
| Registration Number | 381-12-01/38-18-08 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R05CB01 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Summary of risk management plan | download |
